Advertisement
Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc. (ARWR) Stock Overview

Explore Arrowhead Pharmaceuticals, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ARWR●NASDAQ
HealthcareBiotechnology
$75.16
$2.61(3.60%)
U.S. Market opens in 16h 8m
Advertisement

Arrowhead Pharmaceuticals, Inc. (ARWR)

Meyka AI Score

Z

Key Financials

Market Cap10.6B
P/E Ratio-34.41
EPS (TTM)$-2.27
ROE-0.55%
Fundamental Analysis

AI Price Forecasts

1 Month$57.55
3 Months$87.17
1 Year Target$61.89

ARWR Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Arrowhead Pharmaceuticals, Inc. (ARWR) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 51.60, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $61.89.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -34.41 and a market capitalization of 10.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
3.60%
5-Day Change
-4.58%
1-Month Change
-1.61%
3-Month Change
15.45%
6-Month Change
16.24%
Year-to-Date (YTD) Change
13.21%
1-Year Change
348.98%
3-Year Change
114.74%
5-Year Change
-1.29%
All-Time (Max) Change
-97.43%

Contact Information

https://arrowheadpharma.com
626 304 3400
177 East Colorado Boulevard, Pasadena, CA, 91105

Company Facts

609 Employees
IPO DateDec 16, 1993
CountryUS
Actively Trading

Frequently Asked Questions